60
Participants
Start Date
April 30, 2006
Primary Completion Date
December 31, 2008
Study Completion Date
December 31, 2008
Seneca Valley Virus (biological agent)
Dose escalation (starting at 1 × 10\^7 vp/kg), IV (in the vein) over 1 hour in a single administration
New York Oncology Hematology P.C., Albany
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Virginia Oncology Associates, Norfolk
Cancer Centers of the Carolinas, Greenville
Cancer Centers of Florida, Ocoee
Dayton Oncology & Hematology, P.A ., Kettering
Central Indiana Cancer Centers, Indianapolis
Mary Crowley Research Center, Dallas
Tyler Cancer Center, Tyler
Northwest Cancer Specialists - Vancouver Cancer Center, Vancouver
Lead Sponsor
Neotropix
INDUSTRY